At AAOS 2016, Bioventus is introducing the CellXtract™ novel cell and bone marrow extraction tool and SIGNAFUSE™, a bioactive bone graft putty recently acquired from BioStructures.
Source: Bioventus LLC
Other products on display include:
- Recently-launched SUPARTZ-FX five-injection HA
- OsteoAMP® Allogeneic Morphogenetic Protein, acquired from Advanced Biologics
- As well as other Bioventus products, DUROLANE® HA and the EXOGEN® Ultrasound Bone Healing System
At AAOS 2016, Bioventus is introducing the CellXtract™ novel cell and bone marrow extraction tool and SIGNAFUSE™, a bioactive bone graft putty recently acquired from BioStructures.
Source: Bioventus LLC
Other products on display include:
Recently-launched SUPARTZ-FX five-injection HA
OsteoAMP® Allogeneic...
At AAOS 2016, Bioventus is introducing the CellXtract™ novel cell and bone marrow extraction tool and SIGNAFUSE™, a bioactive bone graft putty recently acquired from BioStructures.
Source: Bioventus LLC
Other products on display include:
- Recently-launched SUPARTZ-FX five-injection HA
- OsteoAMP® Allogeneic Morphogenetic Protein, acquired from Advanced Biologics
- As well as other Bioventus products, DUROLANE® HA and the EXOGEN® Ultrasound Bone Healing System
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





